International Flavors & Fragrances Inc. Q3 FY2025 earnings call

Management Statement and Operational Highlights

• Third Quarter Execution: IFF's third quarter results demonstrate continued execution with steady sales, strong adjusted operating EBITDA growth of 7%, and margin improvement of 130 basis points. The company is on track to deliver financial results in line with full-year guidance.
• Strategic Progress: Opened a Scent creative center in Dubai, a Citrus Innovation Center in Florida, and expanded the LMR Natural site in France. Announced strategic collaborations with BASF and Kemira, reduced leverage to approximately 2.5x net debt to EBITDA, authorized a $500 million share repurchase, and made progress on divestitures including Pharma Solutions, Nitrocellulose, and the Soy Crush, Concentrates & Lecithin business.
• Innovation and R&D: Increased investment in R&D and commercial capabilities in Health & Biosciences, with a DEB plant with Kemira on track to start up in 2027. Notable wins in Scent and Taste due to innovation and commercial capabilities, such as the ENVIROCAP technology in laundry and the Miu Miu by L'Oreal Fine Fragrance win.

Segment Performance

• Taste: Sales increased 2% to $635 million, with 2-year average growth of approximately 8.5%. Profitability gains of roughly 2% driven by favorable net pricing and cost discipline.
• Food Ingredients: Achieved sales of $830 million, down 3% versus the prior year, but delivered adjusted operating EBITDA of $106 million, a 24% increase year-over-year. The segment had an excellent quarter in terms of profitability with a 230 basis points improvement in adjusted operating EBITDA margin.
• Health & Biosciences: Achieved $577 million in sales, flat versus the prior year, with 2-year average growth of approximately 6%. Adjusted operating EBITDA grew 3% driven primarily by productivity. The Health business in North America faced challenges but new leadership and innovation investment were mentioned to drive improvement.
• Scent: Delivered strong sales growth with net sales of $652 million, up 5% year-over-year. 2-year average growth remained strong at approximately 7%. Third quarter performance was driven by a 20% increase in Fine Fragrance and low single-digit performance in Consumer Fragrance. Fragrance Ingredients was under pressure but the company is shifting towards higher growth and higher value-added specialties.

Guidance

• Reiterated full-year 2025 guidance: sales expected in the range of $10.6 billion to $10.9 billion and adjusted operating EBITDA between $2 billion and $2.15 billion. On a comparable currency-neutral basis, expected to finish the year at the low end of the 1% to 4% sales growth guidance range and near the midpoint of the 5% to 10% EBITDA growth range. Cautious outlook for Q4 due to macro environment headwinds.
• Expect typical seasonality in Q4 with a step down in absolute sales and margin, and face strong comparables versus the prior year.

Risks

• Macro headwinds, geopolitical challenges, and market uncertainty influencing customers and end consumers. Softness in Food Ingredients and short-term pressures in Health & Biosciences. Pressure in Fragrance Ingredients due to declines in commodities offsetting growth in specialties.

Question and Answer

• Q: Can you provide more color on the Health & Biosciences business in North America?

A: In Health & Biosciences, the Health business in North America has been slow. New leadership with strong commercial and marketing capability has been put in place, and significant investment in innovation pipeline is ongoing. Expect improvements, particularly in the second half of 2026 going into 2027.

• Q: What are the main headwinds to top line in Q4?

A: The largest driver is the macro environment, with soft end market demand, especially in Food Ingredients and HPC. The team is being prudent in forecasting due to these factors.

• Q: Can you elaborate on new wins in Taste and Scent?

A: Examples include the ENVIROCAP Scent encapsulation technology commercialized in laundry with a major CPG company and winning the Miu Miu by L'Oreal Fine Fragrance, driven by focus on commercial pipeline, innovation pipeline, and bringing great technology innovation to customers.